Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ZONOVATE DIN 02435233

Status: Dormant
Holder: NOVO NORDISK CANADA INC
Molecule: TUROCTOCOG ALFA

Health Canada record

Active ingredient(s)TUROCTOCOG ALFA 3000 UNIT
Dosage formPowder For Solution; Kit
RouteIntravenous
ScheduleSCHEDULE D
ClassHuman
ATCB02BD02 COAGULATION FACTOR VIII
Original market date23-Mar-2018
Current status date24-Jul-2026
SourceHealth Canada DPD

Establishment licence of the holder

Novo Nordisk Canada Inc — licence 100175, currently licensed, last inspection rating C (2023-02-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TUROCTOCOG ALFA

DINProductCompanyFormStrengthStatus
02435187ZONOVATENOVO NORDISK CANADA INCKit; Powder For SolutionTUROCTOCOG ALFA 250 UNITDormant
02435195ZONOVATENOVO NORDISK CANADA INCPowder For Solution; KitTUROCTOCOG ALFA 500 UNITDormant
02435217ZONOVATENOVO NORDISK CANADA INCPowder For Solution; KitTUROCTOCOG ALFA 1500 UNITDormant
02435225ZONOVATENOVO NORDISK CANADA INCPowder For Solution; KitTUROCTOCOG ALFA 2000 UNITDormant
02435209ZONOVATENOVO NORDISK CANADA INCPowder For Solution; KitTUROCTOCOG ALFA 1000 UNITDormant

Notices of Compliance

NOCDateSubmissionReason
164082014-12-08New Drug Submission (NDS)
Request a quote for ZONOVATE

How to read a Canadian DIN record